136 related articles for article (PubMed ID: 2068160)
21. Specific uptake of 125-I-metaiodobenzylguanidine in human neuroblastoma cell lines is associated with the neuroblastic cell type.
Iavarone A; Servidei T; Riccardi R; Lasorella A; Mastrangelo R
Prog Clin Biol Res; 1991; 366():447-54. PubMed ID: 2068158
[No Abstract] [Full Text] [Related]
22. Iodine-125-MIBG to treat neuroblastoma: preliminary report.
Sisson JC; Hutchinson RJ; Shapiro B; Zasadny KR; Normolle D; Wieland DM; Wahl RL; Singer DA; Mallette SA; Mudgett EE
J Nucl Med; 1990 Sep; 31(9):1479-85. PubMed ID: 2395016
[TBL] [Abstract][Full Text] [Related]
23. Differential penetration of targeting agents into multicellular spheroids derived from human neuroblastoma.
Mairs RJ; Angerson WJ; Babich JW; Murray T
Prog Clin Biol Res; 1991; 366():495-501. PubMed ID: 2068165
[TBL] [Abstract][Full Text] [Related]
24. The treatment of resistant neuroblastoma with 131I-mIBG: alternative methods of dose prescription.
Fielding SL; Flower MA; Ackery DM; Kemshead J; Lashford LS; Lewis IJ
Radiother Oncol; 1992 Sep; 25(1):73-6. PubMed ID: 1410594
[TBL] [Abstract][Full Text] [Related]
25. International Society of Pediatric Oncology, Italian Society of Radiology and Nuclear Medicine, Italian Society of Biology and Nuclear Medicine, and Associazione Genitori Oncologia Pediatrica. IVth International Workshop in Pediatric Oncology: "The role of MIBG in therapy, diagnosis, and monitoring of neuroblastoma". Rome, Italy, September 22 and 23, 1986. Proceedings.
Med Pediatr Oncol; 1987; 15(4):157-228. PubMed ID: 3657702
[No Abstract] [Full Text] [Related]
26. [Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma].
Guerra P
Pediatr Med Chir; 1990; 12(6):663-8. PubMed ID: 2093889
[TBL] [Abstract][Full Text] [Related]
27. A phase I/II study of 131I mIBG in chemo-resistant neuroblastoma. The United Kingdom Children's Cancer Study Group (UKCCSG).
Lewis IJ; Lashford LS; Fielding S; Flower MA; Ackery D; Kemshead J
Prog Clin Biol Res; 1991; 366():463-9. PubMed ID: 2068161
[No Abstract] [Full Text] [Related]
28. Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms.
Montaldo PG; Lanciotti M; Casalaro A; Cornaglia-Ferraris P; Ponzoni M
Cancer Res; 1991 Aug; 51(16):4342-6. PubMed ID: 1868458
[TBL] [Abstract][Full Text] [Related]
29. [131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.
Klingebiel T; Treuner J; Ehninger G; Keller KD; Dopfer R; Feine U; Niethammer D
Cancer Chemother Pharmacol; 1989; 25(2):143-8. PubMed ID: 2598401
[TBL] [Abstract][Full Text] [Related]
30. Biology of metaiodobenzylguanidine interactions with human neuroblastoma cells.
Iavarone A; Lasorella A; Servidei T; Riccardi R; Troncone L; Mastrangelo R
J Nucl Biol Med (1991); 1991; 35(4):186-90. PubMed ID: 1823815
[TBL] [Abstract][Full Text] [Related]
31. Survival of patients with neuroblastoma treated with 125-I MIBG.
Sisson JC; Shapiro B; Hutchinson RJ; Shulkin BL; Zempel S
Am J Clin Oncol; 1996 Apr; 19(2):144-8. PubMed ID: 8610638
[TBL] [Abstract][Full Text] [Related]
32. Imaging of catecholamine-secreting tumours: uses of MIBG in diagnosis and treatment.
Shapiro B
Baillieres Clin Endocrinol Metab; 1993 Apr; 7(2):491-507. PubMed ID: 8489488
[TBL] [Abstract][Full Text] [Related]
33. SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice.
Clerc J; Halpern S; Fourré C; Omri F; Briançon C; Jeusset J; Fragu P
J Nucl Med; 1993 Sep; 34(9):1565-70. PubMed ID: 8355077
[TBL] [Abstract][Full Text] [Related]
34. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.
De Kraker J; Hoefnagel CA; Caron H; Valdés Olmos RA; Zsiros J; Heij HA; Voûte PA
Eur J Cancer; 1995; 31A(4):600-2. PubMed ID: 7576977
[TBL] [Abstract][Full Text] [Related]
35. The treatment of neuroblastoma with 131I-MIBG.
Mastrangelo R
Med Pediatr Oncol; 1987; 15(4):157-8. PubMed ID: 3657703
[No Abstract] [Full Text] [Related]
36. Problem with mouse neuroblastoma for iodine-131 MIBG studies.
Aboul-Enein HY
J Nucl Med; 1987 Feb; 28(2):255-6. PubMed ID: 3806232
[No Abstract] [Full Text] [Related]
37. 131-Metaiodobenzylguanedine therapy of neuroblastoma in childhood. One year of therapeutic experience.
Schwabe D; Sahm S; Gerein V; Happ J; Kropp-von Rabenau H; Maul F; Baum RP; Manegold K; Nitz C; Hör G
Eur J Pediatr; 1987 May; 146(3):246-50. PubMed ID: 3595643
[TBL] [Abstract][Full Text] [Related]
38. Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study.
Fielding SL; Flower MA; Ackery D; Kemshead JT; Lashford LS; Lewis I
Eur J Nucl Med; 1991; 18(5):308-16. PubMed ID: 1936038
[TBL] [Abstract][Full Text] [Related]
39. Enhanced tumour uptake and in vitro radiotoxicity of no-carrier-added [131I]meta-iodobenzylguanidine: implications for the targeted radiotherapy of neuroblastoma.
Mairs RJ; Russell J; Cunningham S; O'Donoghue JA; Gaze MN; Owens J; Vaidyanathan G; Zalutsky MR
Eur J Cancer; 1995; 31A(4):576-81. PubMed ID: 7576972
[TBL] [Abstract][Full Text] [Related]
40. Normal cerebellar MIBG localization. Implications in the interpretation of delayed scans.
Hattner RS; Pounds TR; Matthay KK
Clin Nucl Med; 1994 Nov; 19(11):985-8. PubMed ID: 7842595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
